Literature DB >> 1933856

Glycosylation at the Fab portion of myeloma immunoglobulin G and increased fucosylated biantennary sugar chains: structural analysis by high-performance liquid chromatography and antibody-lectin enzyme immunoassay using Lens culinaris agglutinin.

N Kinoshita1, M Ohno, T Nishiura, S Fujii, A Nishikawa, Y Kawakami, N Uozumi, N Taniguchi.   

Abstract

An antibody-lectin enzyme immunoassay technique which had been developed for the analysis of sugar chains of alpha-fetoprotein (N. Kinoshita et al., Clin. Chim. Acta, 179: 143-152, 1989) was used for analysis of sugar chains of myeloma immunoglobulin G (IgG). The IgG sugar chains of four of nine patients with myeloma were found to be highly reactive to Lens culinaris agglutinin as compared with those of six normal controls and 177 patients without myeloma. This reflected a high L. culinaris agglutinin/concanavalin A ratio. The IgGs of these patients were found to have highly sialylated, fucosylated, and bisected biantennary sugar chains at Fab portions as judged by the lectin-blotting technique as well as by high-performance liquid chromatography analysis. These results indicate that some of the myeloma IgG proteins undergo unusual glycosylation processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933856

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.

Authors:  Jianhui Zhu; Elisa Warner; Neehar D Parikh; David M Lubman
Journal:  Mass Spectrom Rev       Date:  2018-11-25       Impact factor: 10.946

2.  Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.

Authors:  S C Fleming; S Smith; D Knowles; A Skillen; C H Self
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

3.  The fine specificity of mannose-binding and galactose-binding lectins revealed using outlier motif analysis of glycan array data.

Authors:  Kevin A Maupin; Daniel Liden; Brian B Haab
Journal:  Glycobiology       Date:  2011-08-29       Impact factor: 4.313

4.  Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients.

Authors:  A Youings; S C Chang; R A Dwek; I G Scragg
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

5.  Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.

Authors:  H Leibiger; D Wüstner; R D Stigler; U Marx
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

6.  Capillary (Gel) Electrophoresis-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

Authors:  Samanta Cajic; René Hennig; Robert Burock; Erdmann Rapp
Journal:  Exp Suppl       Date:  2021

7.  Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic RFs which correlate with disease parameters and with the gal(0) glycoform of IgG.

Authors:  M M Newkirk; M J Fournier; J Shiroky
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

8.  Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.

Authors:  Peng-Cheng Xu; Shen-Ju Gou; Xiao-Wei Yang; Zhao Cui; Xiao-Yu Jia; Min Chen; Ming-Hui Zhao
Journal:  BMC Immunol       Date:  2012-03-09       Impact factor: 3.615

9.  Changes in anti-thyroglobulin IgG glycosylation patterns in Hashimoto's thyroiditis patients.

Authors:  Shanshan Yuan; Qianqian Li; Yang Zhang; Chuncui Huang; Hongmei Wu; Yan Li; Yalei Liu; Nan Yu; Hong Zhang; Guizhi Lu; Yanming Gao; Ying Gao; Xiaohui Guo
Journal:  J Clin Endocrinol Metab       Date:  2014-11-07       Impact factor: 5.958

10.  Glycan array analysis of Pholiota squarrosa lectin and other fucose-oriented lectins.

Authors:  López-Cortés Rubén; Muinelo-Romay Laura; Fernández-Briera Almudena; Gil Martín Emilio
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 4.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.